Vaccines
Opinion
Waiting for the under-5 COVID-19 vaccine
This may be yet another instance of when the crafty COVID-19 has moved with a pace that will make an under–age-5 vaccine of relatively little...
From the Journals
Babies of pregnant women who get RSV vaccine likely to be prescribed fewer antimicrobials
Conference Coverage
Norovirus vaccine candidates employ different approaches
From the Journals
‘Overwhelming’ need to study COVID vaccine–associated tinnitus
From the Journals
COVID-19 often more severe with congenital heart defects
“Hospitalized patients with heart defects are up to twice as likely to have critical outcomes of COVID-19 illness,” says author of a new study.
From the Journals
COVID-19 vax effectiveness quantified in immunosuppressed patients
A database study of 154,000 patients found that SARS-CoV-2 vaccines give people taking immunosuppressants significant protection against COVID-19...
Latest News
C. difficile vaccine: Pfizer’s phase 3 CLOVER trial shows mixed results
“I am impressed, from the limited data that have been made available, that the vaccine appears to have efficacy of around 50% for reducing CDI.”...
From the Journals
Double-dose COVID-19 vaccines showed limited effectiveness against Omicron
“For now, we are going to have to realize that it is virtually impossible to prevent mild COVID without frequent boosting.”
Feature
Pan-coronavirus vaccines may be key to fighting future pandemics
Practice Alert
Vaccine update: The latest recommendations from ACIP
Here are the latest recommendations on the hepatitis, pneumococcal, zoster, rabies, and dengue vaccines.
Latest News
Nirsevimab protects healthy infants from RSV
“Nirsevimab has the potential to seriously decrease the annual overwhelming number of RSV infected babies.”